|

ABN401 Clinical Trials

1 actively recruiting trial

Also known as: c-MET inhibitor

Pipeline

Phase 2: 1

Top Sponsors

  • Yonsei University1

Indications

  • Neoplasms1
  • Cancer1

Other1 trial

c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.